Fairscale Capital’s Hims & Hers Health HIMS Stock Holding History

Fairscale Capital’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.85K	Hold	140	–	–	﹤0.01%	347
2026 Q1	$2.91K	Hold	140	–	–	﹤0.01%	366
2025 Q4	$4.55K	Hold	140	–	–	﹤0.01%	333
2025 Q3	$7.94K	Hold	140	–	–	0.01%	340
2025 Q2	$9.27K	Hold	140	–	–	0.01%	331
2025 Q1	$4.14K	Hold	140	–	–	﹤0.01%	275
2024 Q4	$3.38K	Hold	140	–	–	﹤0.01%	285
2024 Q3	$2.58K	Hold	140	–	–	﹤0.01%	295
2024 Q2	$3.23K	Buy	+140	New	+$2.33K	﹤0.01%	293

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fairscale Capital's HIMS Position: Q2 2026 in Review

Fairscale Capital held its Hims & Hers Health (HIMS) position steady in Q2 2026 at 140 shares worth $4.85K. The position accounts for ﹤0.01% of the portfolio, ranked #347.

Fairscale Capital first reported a position in HIMS in Q2 2024 and has held it in 9 quarters since. The position peaked at $9.27K in Q2 2025. 507 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Fairscale Capital held 140 shares of Hims & Hers Health worth $4.85K as of Q2 2026.
Fairscale Capital left its Hims & Hers Health share count unchanged in Q2 2026.
Hims & Hers Health made up ﹤0.01% of Fairscale Capital's portfolio in Q2 2026, its #347 holding.
Fairscale Capital first reported a position in Hims & Hers Health in Q2 2024 and has held it in 9 quarters since.
Fairscale Capital's Hims & Hers Health position peaked at $9.27K in Q2 2025.
507 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.